American Marconi Wireless News

NYSE - LSE

RIO	-3.01%	83.15	$
CMSC	-0.88%	22.65	$
RBGPF	-19.57%	69	$
BCE	0.23%	25.79	$
BTI	-2.35%	57.37	$
GSK	-1.02%	51.84	$
BCC	-2.28%	68.3	$
CMSD	-1.07%	22.658	$
RELX	-1.38%	33.36	$
RYCEF	-8.21%	15.34	$
JRI	-3.31%	11.77	$
VOD	-0.63%	14.33	$
AZN	-2.9%	183.6	$
BP	-2.41%	44.78	$
NGG	-4.32%	81.99	$

Featured

French prosecutors suspect Musk encouraged deepfakes row to inflate X value

French prosecutors said Saturday they had alerted US authorities to a suspicion that tech tycoon Elon Musk had encouraged the controversy over sexualised deepfakes on X to "artificially" increase the value of his company.

Peru's crowded presidential race zeroes in on organized crime

For the 35 candidates vying to be Peru's next president, the question of how to beat back organized crime could be what it takes to break out ahead of the pack.

Last news

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced successful submission and acceptance of the end-of-phase 1 meeting package to FDA and that the company is on track to hold the meeting later this year. The primary purpose of this meeting is to establish agency feedback and input into the clinical development and regulatory approval pathway for Gemini as a treatment for acute kidney injury (AKI).

Who is the best Rhinoplasty Surgeon in Seattle?

The best rhinoplasty in Seattle is by Dr. Sajan

TeleTracking Launches First AI-Powered Patient Throughput Solution, Decision IQ(R)

University of Louisville Health pilots tool to tackle capacity constraints and improve patient flow across its system

LegalEASE Featured on 'Trending Today' TV Series on Fox Business for Pioneering Legal Benefits That Empower Employees Nationwide

The acclaimed television series will highlight how LegalEASE is setting a new standard in legal benefits through innovation, education, and a national network of top-tier attorneys.

In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial

Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the diseaseParenteral support reduction of up to 37% is groundbreaking; No approved treatments exist for MVID in any region

Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation

Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countriesMajor milestone in international growth strategy

VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth

Appointment strengthens execution as the company accelerates AI infrastructure growth.

Licensing Expo 2026 Unveils the World's Largest, Most Influential Brand Licensing Event

More than 200 exhibitors, representing all IP categories, have already signed up; attendee registration is now open with new ticketing options designed to maximize attendee value and ROI.

Vanderbilt Report: How Gaming Veterans are Fixing Travel's $8 Billion Conversion Problem

BRISTOL, TN / ACCESS Newswire / November 20, 2025 / Something odd is happening in the travel industry. Companies pour nearly $8 billion into digital advertising annually, double what they spent just two years ago.

Tosca Launches New Poultry RPC to Serve Surging Specialty Cuts and Small-Batch Processing

Smaller footprint, stronger structure, and leak-containing design support the industry's shift toward premium poultry SKUs.

Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach

~ FDA Response Streamlines Path to Commercial Production of PF614~

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine franchise from three to up to six approved products by 2028Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogeneFurther improves 2026 and 2027 expected GAAP operating expenses by approximately $0.5 billion each year on path to targeted cash breakeven in 2028

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash breakeven by 2028

ESSE Care Welcomes Dr. Amanda Chu, Expanding Complex Minimally Invasive Surgery Offerings and Endometriosis Specialty Care

With elite training in endometriosis excision and a commitment to whole-body, multidisciplinary care, Dr. Chu expands ESSE's mission of integrative, patient-centered treatment for complex gynecologic conditions.

Wellgistics Health Reports Third Quarter 2025 Financial Results and Provides Business Update

TAMPA, FL / ACCESS Newswire / November 20, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the individual patient fulfillment of prescription drug through pharmacies 'From Manufacturer To Patient', today reported financial results for the period ended September 30, 2025 on Form 10-Q on November 19, 2025[1] and provided a business update from the CEO.

Tom Brady's 1-of-1 Game-Worn NFL Logo Patch Autograph Card Set to Breach Six Figures at Fanatics Collect Premier Auction Tonight

No Reserve | Auction Ends Tonight, Thursday, November 20, 2025

BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform

VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the Eurasian Patent Organization (EAPO) has officially granted Patent No. 051510 (issued November 14, 2025).

Argentine court orders $500 mn forfeiture in ex-pres. Kirchner graft case

An Argentine court has ordered nearly $500 million in assets seized from ex-president Cristina Kirchner and other beneficiaries of a corruption scheme for which she is serving a six-year sentence.

Argentine court orders assets worth $500 mn seized in ex-president Kirchner's graft case

An Argentine court has ordered nearly $500 million in assets seized from ex-president Cristina Kirchner and other beneficiaries of a corruption scheme for which she is serving a six-year sentence.

Top French wine show risks purists' ire with alcohol-free drive

A top French wine salon risks upsetting the traditional defenders of the country's famed viticulture by handing over increased space to the booming alcohol-free sector.

Macron slams 'bourgeois' drug users as French activist says won't be silenced

French President Emmanuel Macron on Wednesday accused urban middle class drug users of fuelling a narcotics-driven crime wave that has caused alarm nationwide, and a wave of murders in the second city of Marseille.

Arsenal to end partnership with Visit Rwanda

Premier League leaders Arsenal will end their partnership deal with Rwanda at the end of this season, the African country's development board announced on Wednesday.

Thousands of Kenyans displaced by Lake Naivasha flooding

The tourist boats that normally ply Kenya's famed Lake Naivasha have had a different task in recent weeks: evacuating hundreds of flooded homes.

Under pressure, EU to scale back digital rules

The EU will unveil plans on Wednesday to overhaul its AI and data privacy rules after coming under pressure from European and US companies.

Medicure Reports Financial Results for Quarter Ended September 30, 2025

WINNIPEG, MB / ACCESS Newswire / November 19, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported its results from operations for the quarter ended September 30, 2025.

Bradford Custom Homes Featured on 'Trending Today' on Fox Business for Its Purpose Driven and Wellness Minded Approach to Luxury Homebuilding

ATLANTA, GEORGIA / ACCESS Newswire / November 19, 2025 / Bradford Custom Homes, a leading Southeastern luxury home builder known for its values driven and wellness minded approach to design and construction, will be featured on an upcoming episode of "Trending Today" airing Saturday, November 23 at 5:30 PM ET on Fox Business. The episode offers a behind the scenes look at how Bradford creates legacy grade homes through craftsmanship, intentional planning, and a client first philosophy.

Desert Oasis Healthcare's Yucca Valley Primary Care Clinic Wins "Best of the Best - Readers' Choice Award"

Honored for Delivering Exceptional Primary Care to the Morongo Basin Community

Elle Communications is Agency of Record for FDA-Cleared Neurostimulation Device

NET Recovery Announces National Treatments Amid Addiction Crisis

CASI Pharmaceuticals Announces Changes in Board Governance

James Huang appointed as Non-Executive Chairman of CASI Board of Directors

Report: Major Flaws in CMS Nursing Home Quality Measure Hindering Alzheimer's Care

Project PAUSE Urges Reform of Nationwide Metric Used to Determine Prescribing Antipsychotics in Long-Term Care Settings

LAW90 Launches Revolutionary AI Positioning Program, Expands Into Texas Market, and Announces National Hiring for 2026

HENDERSON, NV / ACCESS Newswire / November 19, 2025 / PAO Group, Inc. (PAOG:OTC), LAW90, a leading innovator in legal advertising, technology and attorney performance enhancement, today announced the launch of its groundbreaking AI Positioning Program, a proprietary system designed to give attorneys a powerful competitive advantage in case preparation, strategy, and litigation outcomes.

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

BOCA RATON, FLORIDA / ACCESS Newswire / November 19, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) ("Entero" or the "Company") today announced that its subsidiary Grid AI has executed a Letter of Intent (LOI) with a stealth-mode hyperscaler artificial intelligence (AI) data-center developer to deploy Grid AI's advanced power-cluster optimization and orchestration platform at the customer's first large-scale AI campus. The campus-expected to be among the more sophisticated AI-ready digital-infrastructure sites in development-will be located in the ERCOT market in Texas.

American Marconi Wireless News - Boulevard (English)